GT Biopharma Inc. – Filings and Transcripts

NASDAQ: GTBP
Share price (7/10/26): $0.42
Market cap (7/10/26): $18.8 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 06/30/25 Q2 2025 – amended

ended 09/30/25 Q3 2025 – amended

ended 12/31/25 FY 2025

ended 09/30/25 Q3

Prospectuses and Registrations Filter

Prospectus supplement

Initial registration of new securities

Prospectus supplement

Initial registration of new securities

Prospectus supplement

Ownership Filter

Urban Alan Louis

Mun-Gavin David C.

Casamento Charles J

Breen Michael Martin

News Filter

Amendment to Articles of Incorporation or Bylaws, or Change in Fiscal Year, Financial Statements or Exhibits

Notice of Delisting, Failure to Satisfy Listing Rule, or Transfer of Listing, Financial Statements or Exhibits

Material Definitive Agreement, Financial Statements or Exhibits

Non-Reliance on Previously Issued Financial Statements or Related Audit Report or Completed Interim Review, Financial Statements or Exhibits

Notice of Delisting, Failure to Satisfy Listing Rule, or Transfer of Listing, Financial Statements or Exhibits

Proxies Filter

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Other Filter

Notice of effectiveness

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness